These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7918119)

  • 1. Role of 21-deoxyaldosterone in human hypertension.
    Abdelhamid S; Lewicka S; Bige K; Haack D; Lorenz H; Nensel U; Röckel A; Fiegel P; Walb D; Vecsei P
    J Steroid Biochem Mol Biol; 1994 Sep; 50(5-6):319-27. PubMed ID: 7918119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new subset of mineralocorticoid hypertension with excess of 21-deoxyaldosterone and Kelly's-M1 steroid: clinical and morphological findings.
    Abdelhamid S; Lewicka S; Vecsei P; Haack D; Pahl S; Remberger K; Müller-Lobeck H; Bönhof JA; Nensel U; Röckel A
    J Clin Endocrinol Metab; 1995 Mar; 80(3):737-44. PubMed ID: 7883826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of aldosterone metabolite Kelly-M1 in patients with adrenal dysfunction.
    Lewicka S; Vecsei P; Bige K; Fisher T; Winter J; Abdelhamid S; Heinrich U; Bokkenheuser VD
    J Steroid Biochem; 1988 Mar; 29(3):333-9. PubMed ID: 3258645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 21-Deoxyaldosterone excretion in patients with primary aldosteronism and 21-hydroxylase deficiency.
    Lewicka S; Winter J; Bige K; Bokkenheuser V; Vecsei P; Abdelhamid S; Heinrich U
    J Clin Endocrinol Metab; 1987 Apr; 64(4):771-7. PubMed ID: 3493258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension.
    Gordon RD; Gomez-Sanchez CE; Hamlet SM; Tunny TJ; Klemm SA
    J Hypertens Suppl; 1987 Dec; 5(5):S103-6. PubMed ID: 2832571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of 21-deoxyaldosterone by rat adrenal tissue in vitro: evidence for an alternative biosynthetic pathway of aldosterone.
    Lewicka S; Bige K; Weindel K; Winter J; Pies W; Vecsei P
    Acta Endocrinol (Copenh); 1990 Aug; 123(2):225-30. PubMed ID: 2171292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
    Witzgall H; Lorenz R; von Werder K; Weber PC
    Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The steroid content of adrenal adenomas and measurements of aldosterone production in patients with essential hypertension and primary aldosteronism.
    Kaplan NM
    J Clin Invest; 1967 May; 46(5):728-34. PubMed ID: 6025479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation in the excretion of different aldosterone metabolites and unmetabolized ('free') aldosterone in hypertension.
    Abdelhamid S; Vecsei P; Haack D; Gless KH; Walb D; Lichtwald K; Fiegel P
    Clin Sci (Lond); 1979 Nov; 57(5):409-14. PubMed ID: 519948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal transitional zone steroids, 18-oxo and 18-hydroxycortisol, useful in the diagnosis of primary aldosteronism, are ACTH-dependent.
    Hamlet SM; Gordon RD; Gomez-Sanchez CE; Tunny TJ; Klemm SA
    Clin Exp Pharmacol Physiol; 1988 Apr; 15(4):317-22. PubMed ID: 2856057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro studies in primary aldosteronism: baseline steroid production and aldosterone responses to ACTH and angiotensin II.
    Pham-Huu-Trung MT; Duclos JM; Pagny JY; Bogyo A; Leneuve P; Girard F
    Acta Endocrinol (Copenh); 1988 Jan; 117(1):135-44. PubMed ID: 2837882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro responses of aldosterone-producing adenomas to angiotensin II and ACTH after treatment with spironolactone before adrenalectomy.
    Wisgerhof M
    J Lab Clin Med; 1984 Aug; 104(2):160-5. PubMed ID: 6086794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses of aldosterone-producing adenomas to ACTH and angiotensins.
    Saruta T; Okuno T; Eguchi T; Nakamura R; Saito I; Kondo K; Oka M; Matsuki S
    Acta Endocrinol (Copenh); 1979 Dec; 92(4):702-9. PubMed ID: 231371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on abnormalities of adrenal steroidogenesis in essential hypertension, primary aldosteronism and renovascular hypertension: responses of plasma steroids to angiotensin III].
    Itoh N
    Nihon Naibunpi Gakkai Zasshi; 1988 May; 64(5):419-38. PubMed ID: 3410145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of 19-noraldosterone, 18, 19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism.
    Takeda Y; Miyamori I; Iki K; Takeda R; Vecsei P
    Acta Endocrinol (Copenh); 1992 Jun; 126(6):484-8. PubMed ID: 1642080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II receptors and in vitro aldosterone responses of aldosterone-producing adenomas, adjacent nontumorous tissue, and normal human adrenal glomerulosa.
    Brown G; Douglas J; Bravo E
    J Clin Endocrinol Metab; 1980 Oct; 51(4):718-23. PubMed ID: 6252223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism.
    Kem DC; Weinberger MH; Gomez-Sanchez C; Higgins JR; Kramer NJ
    J Lab Clin Med; 1976 Aug; 88(2):261-70. PubMed ID: 182890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of aldosterone secretion in primary aldosteronism.
    Spark RF; Dale SL; Kahn PC; Melby JC
    J Clin Invest; 1969 Jan; 48(1):96-104. PubMed ID: 4303791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension.
    Markou A; Sertedaki A; Kaltsas G; Androulakis II; Marakaki C; Pappa T; Gouli A; Papanastasiou L; Fountoulakis S; Zacharoulis A; Karavidas A; Ragkou D; Charmandari E; Chrousos GP; Piaditis GP
    J Clin Endocrinol Metab; 2015 Aug; 100(8):2857-64. PubMed ID: 25974737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.